Brainstorm Cell Therapeutics Proxy Statement Filed
Ticker: BCLI · Form: DEF 14A · Filed: May 16, 2025 · CIK: 1137883
| Field | Detail |
|---|---|
| Company | Brainstorm Cell Therapeutics Inc. (BCLI) |
| Form Type | DEF 14A |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Brainstorm Cell Therapeutics (BCLI) proxy filed for June 25 meeting. Shareholders vote soon.
AI Summary
Brainstorm Cell Therapeutics Inc. filed its definitive proxy statement on May 16, 2025, for its annual meeting on June 25, 2025. The company, formerly known as Golden Hand Resources Inc. and Wizbang Technologies Inc., is in the biological products sector and is incorporated in Delaware.
Why It Matters
This filing provides shareholders with crucial information regarding the upcoming annual meeting, including voting matters and company governance, which can impact investment decisions.
Risk Assessment
Risk Level: medium — Proxy statements often contain information about executive compensation, board structure, and shareholder proposals, which can signal potential changes in company strategy or governance that may affect risk.
Key Numbers
- 20250625 — Annual Meeting Date (Shareholders will vote on matters presented in this proxy statement.)
- 20250516 — Filing Date (The date the definitive proxy statement was submitted to the SEC.)
Key Players & Entities
- BRAINSTORM CELL THERAPEUTICS INC. (company) — Filer
- 20250625 (date) — Annual Meeting Date
- 20250516 (date) — Filing Date
- GOLDEN HAND RESOURCES INC (company) — Former Company Name
- WIZBANG TECHNOLOGIES INC (company) — Former Company Name
FAQ
What is the primary purpose of this DEF 14A filing?
This filing is a definitive proxy statement for Brainstorm Cell Therapeutics Inc., providing shareholders with information for the upcoming annual meeting on June 25, 2025.
When is the annual meeting scheduled?
The annual meeting of shareholders for Brainstorm Cell Therapeutics Inc. is scheduled for June 25, 2025.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on May 16, 2025.
What were some of the former names of Brainstorm Cell Therapeutics Inc.?
The company was formerly known as Golden Hand Resources Inc. and Wizbang Technologies Inc.
What industry does Brainstorm Cell Therapeutics Inc. operate in?
Brainstorm Cell Therapeutics Inc. operates in the Biological Products sector, specifically under SIC code 2836.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 16, 2025 regarding BRAINSTORM CELL THERAPEUTICS INC. (BCLI).